In the blood: Catching cancer before it strikes again 
 By Brandon Raeburn, Media & Content Specialist
 
A woman standing, looking at the camera

Former Duke-NUS post-doctoral fellow Dr Debleena Ray has designed the grandest of experiments of her life: Building her own startup // Credit: Courtesy of Debleena Ray


Cancer recurrence is often deadlier than the original disease, especially when it spreads undetected. Yet for survivors, post-treatment monitoring can be a financial, emotional and mental burden—relying on costly, invasive tests with no guarantees.

But what if detecting cancer was as simple as a blood test?

In this episode, Dr Debleena Ray, the founder of the biotech startup 2Strands Biosciences and a former Duke-NUS post-doctoral fellow, shares how she’s bridging research and entrepreneurship to develop cutting-edge, blood-based tests that will revolutionise cancer monitoring.

Listen now:

What’s inside this episode:

  • The story behind 2Strands Biosciences and Ray’s vision for the future of cancer detection
  • How her love for science began—and what fuels her passion
  • The leap from academia to entrepreneurship—and the lessons learned
  • Her advice for aspiring scientist-entrepreneurs looking to make an impact

Enjoyed this episode and want to listen to more? Check out our previous episodes:



Show credits for Episode 14:

Hosted by: Brandon Raeburn
Produced by: Sean Firoz, Helmy Sa’at and Nicole Lim 

 


You can also listen to MEDICUS - the Podcast on Apple Podcasts and Spotify.
Get the latest news and features delivered to your inbox.
SUBSCRIBE TO MEDICUS